Ambev S.a.
ABEV NYSE· Beverages
Last close · Oct 30, 2026
$2.66
KIRA · Stoqly’s AI analyst, in plain words
- Ambev S.a. had $15.8B of revenue in fiscal 2025, down 4.9% on the year before. Over five years, revenue changed +6.9% a year on average.
- Its operating margin was 26.4%, up 2.1 pts: of every 100 in sales, about 26 is left after running the business.
- Ambev S.a. made $2.8B of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew −2.8% a year.
- Free cash flow was $3.6B in fiscal 2025, 22.5% of revenue.
- Ambev S.a. has $2.8B more cash than debt.
Market cap
$41.7B
P/E
15.0x
Revenue
$15.8B
Net income
$2.8B
Free cash flow
$3.6B
Operating margin
26.4%
Ambev S.a. in 30 seconds · fiscal 2025
Are sales growing?
−4.9%
No. Sales fell 4.9% last year.
Does it make a profit?
17.6%
Yes. It keeps 17.6% of every sale as profit.
Does profit turn into cash?
22.5%
Yes. 22.5% of sales ends up as free cash.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
6 / 9
Mixed. It passes 6 of 9 health tests.
How is the share priced?
15.0x
One share costs 15.0 times its yearly profit per share.
What Ambev S.a. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Mar 3, 2026
- Legal name
- AMBEV S.A.
- CIK
- 0001565025
Ambev S.a. · ABEV · stoqly.net
Results and finances
The last 5 fiscal years. Amounts in USD. Compiled by stoqly.net.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $13.5B | $15.4B | $16.0B | $16.6B | $15.8B |
| Revenue growth | 19.3% | 14.2% | 3.5% | 4.0% | −4.9% |
| Gross margin | 51.1% | 49.3% | 50.7% | 51.2% | 51.4% |
| Operating margin | 23.4% | 22.2% | 23.6% | 24.4% | 26.4% |
| Net income | $2.3B | $2.8B | $2.9B | $2.7B | $2.8B |
| Net margin | 17.4% | 18.1% | 18.2% | 16.1% | 17.6% |
| Diluted EPS | $0.15 | $0.18 | $0.18 | $0.17 | $0.18 |
| Cash | |||||
| Cash from operations | $4.2B | $4.0B | $4.9B | $4.8B | $4.4B |
| Capital expenditure | $1.4B | $1.3B | $1.2B | $881M | $821M |
| Free cash flow | $2.8B | $2.7B | $3.7B | $4.0B | $3.6B |
| FCF margin | 20.9% | 17.7% | 23.5% | 23.9% | 22.5% |
| Dividends paid | $491M | $69.2M | $109M | — | — |
| Share buybacks | $0.0M | $0.0M | — | $319M | — |
| Share count change | −0.1% | −0.1% | −0.1% | −0.2% | −0.8% |
| Debt and strength | |||||
| Cash and short-term investments | $3.0B | $2.8B | $3.3B | $4.6B | $3.4B |
| Debt incl. finance leases | $7.6B | $8.2B | $722M | $558M | $618M |
| Shareholders' equity | $14.8B | $15.5B | $16.3B | $15.9B | $16.0B |
| Current ratio | 1.0x | 0.9x | 0.9x | 1.1x | 1.0x |
| Interest coverage | 11.9x | 7.6x | 7.7x | 5.4x | 5.3x |
| Returns and quality | |||||
| Return on capital | 16.3% | 15.7% | 27.5% | 26.9% | 24.8% |
| Return on equity | 16.2% | 18.4% | 18.3% | 16.6% | 17.3% |
| Return on tangible equity | 41.5% | 46.0% | 45.6% | 39.7% | 43.0% |
| Piotroski F-score | 6 | 6 | 6 | 8 | 6 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$2.6M
5 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Ambev S.a. · ABEV · stoqly.net
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $2.66 a share, the company is worth $41.7B: 15.0 times its earnings of the last four quarters.
Compiled and analysed by stoqly.net from SEC EDGAR XBRL filings (CIK 0001565025). Latest version: stoqly.net/companies/abev. Data updated November 1, 2026. Filed in BRL under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.